Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2010
12/16/2010US20100317712 Estrogen Agonists/Antagonists For Preventing Breast Cancer
12/16/2010US20100317710 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom
12/16/2010US20100317709 Sphingosine-1-phosphate (s1p) receptor compounds
12/16/2010US20100317701 Heterocyclic inhibitors of necroptosis
12/16/2010US20100317676 Fused heterocyclic compounds, and compositions and uses thereof
12/16/2010US20100317674 Metabotropic Glutamate-Receptor-Potentiating Isoindolones
12/16/2010US20100317671 Xanthine-based cyclic gmp-enhancing rho-kinase inhibitor inhibits physiological activities of lung epithelial cell line
12/16/2010US20100317669 Novel substituted piperidyl-propane-thiols
12/16/2010US20100317654 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
12/16/2010US20100317652 Compounds Useful In Therapy
12/16/2010US20100317649 S1P Receptor Modulating Compounds and Use Thereof
12/16/2010US20100317639 Medicament Based On a Monoester of Steroids With Long Chain Fatty Acids
12/16/2010US20100317635 Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
12/16/2010US20100317634 Piperidyl-propane-thiol ccr3 modulators
12/16/2010US20100317628 MicroRNA Modulators and Method for Identifying and Using the Same
12/16/2010US20100317618 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1 and cx3cr1
12/16/2010US20100317611 Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
12/16/2010US20100317584 Pharmaceutical composition, package and method for rapidly reducing the uric acid in blood
12/16/2010US20100317582 Novel cyclic hydrocarbon compounds for the treatment of diseases
12/16/2010US20100317578 Method of protecting against stroke through the use of a delta opioid peptide
12/16/2010US20100317575 Pharmaceutical composition comprising a pyrazole-o-glucoside derivative
12/16/2010US20100316750 Cholesterol lowering supplement
12/16/2010US20100316730 Treatment of cardiovascular diseases with ozone
12/16/2010US20100316727 Treatment of inflammatory disorders with ozone
12/16/2010US20100316711 Nifedipine containing opress coated tablet and method of preparing same
12/16/2010US20100316706 Carbocyclic and oxacarbocyclic fumaric acid oligomers
12/16/2010US20100316701 Compositions and method for manipulating pim-1 activity in circulatory system cells
12/16/2010US20100316651 Cardiovascular related uses of il-1beta antibodies and binding fragments thereof
12/16/2010US20100316622 Diagnosis and treatment of cardiac disorders
12/16/2010US20100316605 Inhibitors of phosphatidylinositol 3-kinase
12/16/2010US20100316602 Compositions and methods for treatment of angiogenesis in pathological lesions
12/16/2010US20100316573 Organic Compounds
12/16/2010CA2765171A1 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
12/16/2010CA2765129A1 Chemical modification motifs for mirna inhibitors and mimetics
12/16/2010CA2764822A1 New potent anti apob antisense compounds
12/16/2010CA2764587A1 Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate
12/16/2010CA2764562A1 Vaccine therapy for choroidal neovascularization
12/16/2010CA2764472A1 Aptamer for chymase, and use thereof
12/16/2010CA2764105A1 Growth hormone polypeptides and methods of making and using same
12/16/2010CA2760588A1 Fluorinated aminotriazole derivatives
12/15/2010EP2261333A2 Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides
12/15/2010EP2261251A2 Methods for the synthesis of a modified hemoglobin solution
12/15/2010EP2261249A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261248A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261247A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261235A2 Inhibitors of caspases
12/15/2010EP2261234A2 Inhibitors of caspases
12/15/2010EP2261233A2 Inhibitors of caspases
12/15/2010EP2261232A2 Inhibitors of caspases
12/15/2010EP2261210A1 3-substituted sulfonyl piperazine derivative
12/15/2010EP2261200A2 Modified forms of pharmacacologically active agents and uses therefor
12/15/2010EP2260903A1 C-19 steroids for therapeutic uses
12/15/2010EP2260872A2 Polymer conjugates of interferon beta-1A and uses thereof
12/15/2010EP2260869A2 Pharmaceutical product
12/15/2010EP2260867A1 TWEAK receptor agonists as anti-angiogenic agents
12/15/2010EP2260842A2 Uses of perfluorinated carboylic acid derivatives for the manufacture of a medicament for the modulation of body mass
12/15/2010EP2260838A1 Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug
12/15/2010EP2260101A1 Microrna (mirna) and downstream targets for diagnostic and therapeutic purposes
12/15/2010EP2260017A1 Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders
12/15/2010EP2000465B1 Triazolone derivative
12/15/2010EP1914232B1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivatives
12/15/2010EP1748774B1 Compositions comprising flavonoids and tocotrienols and uses thereof
12/15/2010EP1694645B1 Amlodipine gentisate and a method of its preparation
12/15/2010EP1537146B1 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections
12/15/2010EP1423380B1 Pyrazole-derived kinase inhibitors and uses thereof
12/15/2010CN201668750U Compound amlodipine, valsartan and hydrochlorothiazide capsule
12/15/2010CN1989985B Chuanxiong rhizome effective ingredient, preparing method, preparation and use thereof
12/15/2010CN1981818B Chinese-medicinal composition, preparation and use for treating cardiovascular diseases
12/15/2010CN1981811B Danshen effective component, its preparation, making method and usage
12/15/2010CN1956716B Medicine capable of inhibiting activation of transcription factor KLF5
12/15/2010CN1939357B Preparation of Ginkgo Damo injection
12/15/2010CN1927346B Mailuoning injection and preparation thereof
12/15/2010CN1919848B bilobalide K and complex thereof, preparation method and use for the same
12/15/2010CN1919222B Process for preparing notoginsen triterpenes
12/15/2010CN1917866B Use of treprostinil, its derivant or pharmaceutically acceptable salt, in preparing medicine to treat and prevent ischemic lesions
12/15/2010CN1915429B Combinations of the peroxisome proliferator-activated receptor (ppar) activator and sterol absorption inhibitor
12/15/2010CN1872259B Composition of medicine for treating coronary heart disease
12/15/2010CN1872191B Drop pills of 'Yixintong' and prepartion method
12/15/2010CN1853670B Coronary heart Danshen root micropellets and preparation thereof
12/15/2010CN1824292B Medicine for improving brain function its preparation method and use
12/15/2010CN1785248B Effervescent of compounding medicines
12/15/2010CN1778342B Chinese medicine composition for treating coronary heart disease
12/15/2010CN1778338B Chinese medicine composition for treating coronary heart disease and angina cordis
12/15/2010CN1708480B Carotenoid analogs for the inhibition and amelioration of disease
12/15/2010CN101918362A Pyridine derivatives
12/15/2010CN101918022A Activin receptor-like kinase-1 compositions and methods of use
12/15/2010CN101917990A Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
12/15/2010CN101914541A Inhibitor for inhibiting expression of MBD2 and application thereof
12/15/2010CN101914168A Medical applications and preparation methods of Pleurotus ferulae Lanzi polysaccharide and composites thereof
12/15/2010CN101914135A Broad-spectrum chemokine receptor antagonistic polypeptide and application thereof
12/15/2010CN101912617A Application of MG53 gene to treatment of insulin resistance, type II diabetes mellitus and related diseases thereof
12/15/2010CN101912572A Multi-effect external plaster
12/15/2010CN101912567A Chinese medicinal prescription for treating chronic myocarditis
12/15/2010CN101912566A Traditional Chinese medicine for treating palpitation
12/15/2010CN101912561A Medicament for treating cerebral infarction
12/15/2010CN101912547A Medicament for treating dizziness and preparation method thereof
12/15/2010CN101912542A Chronic haemorrhoid rapid eliminating drug
12/15/2010CN101912540A Medicament for treating cerebral infarction
12/15/2010CN101912530A Method for ultrasonically extracting general flavone from chloranthus japonicus
12/15/2010CN101912529A Method for extracting total flavones of chloranthus multistachys by using ultrasonic waves
1 ... 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 ... 1595